MonTa Biosciences logo

MonTa Biosciences ApS

MonTa Biosciences is a start-up biotech company located in the largest university park in Denmark and is working on the development of a novel Cancer Immunotherapy technology.

MonTa Biosciencess Monocytes Targeting technology has been developed in collaboration between Bioneer A/S and DTUNanotech.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://montabiosciences.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Produktionstorvet Building 423, first floor2800 Kgs
Lyngby
Denmark
Email
Contact Number
+45 51186306

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”” connections=”true” suffix=””]

MonTa Biosciencess is developing proprietary technology for targeting monocytes and delivery of a toll-like receptor (TLR) agonist in fresh blood using liposomes with a positively charged surface chemistry.

In 2014, MonTa Biosciences was awarded a _Proof-of-Concept” grant from Copenhagen Spin-puts” to support the early development of the company. It also received a Pre-Seed Grant from Novo Seeds.